HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 21201739, compound → HCID 21201849, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 21201739 | HCID 21201739 | — |
| Reactant | HCID 21201831 | HCID 21201831 | — |
| Product | HCID 21201849 | HCID 21201849 | — |
Reaction Steps
Step 2 of Example 10 was repeated except that 1-(2-toluoylmethyl)-2-oxo-3-tert-butoxycarbonylamino-5-benzyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine that obtained from Step 2 of Example 24 was used instead of 1-tert-butylcarbonylmethyl-2-oxo-3-tert-butoxycarbonylamino-5-pivaloyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine, to thereby obtain the title compound.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06239131B1 |
| Source dataset | uspto-grants-2001_05 |
| ORD ID | ord-100202f3781c485db127a54827a7fa6d |
| Source note | uspto-grants-2001_05 |